Shanghai Pharmaceuticals to review Q3 results, interim dividend on October 30

Shanghai Pharmaceuticals Holding Co., Ltd. has announced a board meeting to be held on Thursday, October 30, 2025. The primary purpose of this meeting is to approve the company's third-quarterly results for the nine months ended September 30, 2025, and to consider the payment of an interim dividend, if any. The announcement was made from Shanghai, PRC, on October 17, 2025.

As of the announcement date, the executive directors of the company include Mr. YANG Qiuhua, Mr. SHEN Bo, Mr. LI Yongzhong, and Mr. DONG Ming. Mr. ZHANG Wenxue serves as the non-executive director, while Mr. GU Zhaoyang, Mr. Manson FOK, Mr. WANG Zhong, and Ms. MAN Kwan are the independent non-executive directors. Mr. YANG Qiuhua also holds the position of chairman.

The company, a joint stock company incorporated in the People's Republic of China with limited liability, uses the stock code 02607 for identification purposes.